This inventor holds 2 USPTO granted patents. Top assignee: Neurotech Co., Ltd.. Active years: 2005-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2007
Title: Sung-Hwa Yoon: Inspiring Innovations in Neurodegenerative Diseases
Introduction:
Sung-Hwa Yoon, a distinguished inventor based in Kyunggi-do, KR, has captured the admiration of the global scientific community with his passion for innovation and unwavering commitment to excellence. With a total of 2 patents to his name, Sung-Hwa Yoon is paving the way for groundbreaking advances in the field of neurodegenerative diseases.
Latest Patents:
Sung-Hwa Yoon's latest patents revolve around tetrafluorobenzyl derivatives and pharmaceutical compositions designed to prevent and treat acute and chronic neurodegenerative diseases in the central nervous system. These inventions have significant implications for conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, and stroke, demonstrating Sung-Hwa Yoon's profound impact on the healthcare industry.
Career Highlights:
Currently affiliated with Neurotech Co., Ltd., Sung-Hwa Yoon continues to drive innovation within the company by spearheading research projects focused on advancing treatments for neurodegenerative disorders. His expertise and dedication have led to the development of cutting-edge pharmaceutical compositions that show promise in revolutionizing the field of neurology.
Collaborations:
Sung-Hwa Yoon's collaborative spirit is evident through his partnerships with esteemed colleagues such as Byoung-Joo Gwag and Ho-Sang Moon. Together, they form a dynamic team that thrives on scientific inquiry and the pursuit of novel solutions to complex medical challenges.
Conclusion:
In conclusion, Sung-Hwa Yoon stands as a beacon of inspiration for aspiring inventors and researchers worldwide. His innovative contributions to the field of neurodegenerative diseases not only showcase his technical prowess but also underscore his deep-seated commitment to improving patient outcomes and advancing medical science. Sung-Hwa Yoon's legacy will undoubtedly endure as future generations build upon his groundbreaking discoveries in pursuit of a healthier, more sustainable world.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile